Adding engineered human blood vessel-forming cells to islet transplants boosted the survival of the insulin-producing cells and reversed diabetes in a preclinical study. The new approach, which ...

Telomir Pharmaceuticals (NASDAQ: TELO) announced a breakthrough with its Telomir-1 platform, successfully stabilizing both Silver(I) (Ag+) and highly ...

Adding engineered human blood vessel-forming cells to islet transplants boosted the survival of the insulin-producing cells ...

MIAMI, FLORIDA / ACCESS Newswire / February 21, 2025 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), or Telomir, a leader in age-reversal science, ...

The global Orthobiologics Market is valued at $6.56 billion in 2024 and is projected to reach a value of $10.4 billion by ...

At Regenity Biosciences, our focus is on making a material difference in the lives of patients by transforming bioresorbable materials into life- ...

Not all scars are created equal. That's the conclusion of a new study by Weizmann Institute of Science researchers: They found that two distinct types of scars, referred to as "hot" and "cold," can ...

United Kingdom 3D Bioprinted Human Tissue MarketThe United Kingdom’s 3D bioprinted human tissue market is poised for significant expansion, with the market size projected to increase from USD 52.0 ...

Peptides, as versatile biomolecules, continue to gain traction in various scientific fields due to their wide range of ...

The global amniotic membrane market, valued at USD 1,510.6 million in 2024, is projected to exceed USD 2,279.5 million by 2034, growing at a CAGR of 4.2% over the forecast period. This growth is ...